Early HIV Treatment Prolongs Life

One of the largest clinical drug trials has been stopped a year early because of the undeniably positive results. The federal health officials announced earlier this week that they were ending a clinical trial regarding early treatment for HIV because the trial results were clear early on.

The Centers for Disease Control and Prevention states there are several factors which prevent HIV-positive people from getting an early diagnosis, such as lack of insurance or wrong diagnosis. Dr. Demetre C. Daskalakis, the NYC health department’s assistant commissioner for H.I.V./AIDS prevention and control, says that treatment is being started quickly for newly diagnosed HIV patients in New York. Dr. Julio S. G. Montaner, a former president of the International AIDS Society, says early treatment is the best way to halt the AIDS epidemic.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below